Skip to main content

Table 6 Results of the survival analysis of the 75 significant mRNAs identified by LRSC

From: Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)

Entrez ID

Symbol

TCGA median log-rank

LIRI-JP median log-rank

5036

PA2G4

1.47E−03

5.30E−06

3838

KPNA2

1.40E−02

1.30E−05

57405

SPC25

3.05E−02

1.55E−05

8550

MAPKAPK5

2.79E−02

4.44E−05

55143

CDCA8

2.61E−02

7.28E−05

1776

DNASE1L3

2.16E−02

2.49E−04

54538

ROBO4

1.37E−02

2.98E−04

5138

PDE2A

6.89E−03

3.17E−04

25956

SEC31B

1.85E−03

3.22E−04

6421

SFPQ

8.09E−04

1.37E−03

55706

NDC1

4.12E−02

2.01E−03

51380

CSAD

1.70E−02

2.02E−03

2665

GDI2

4.79E−02

2.78E−03

8520

HAT1

1.35E−02

3.04E−03

2519

FUCA2

4.19E−02

3.06E−03

51026

GOLT1B

2.92E−03

6.00E−03

29889

GNL2

2.63E−03

7.94E−03

790

CAD

2.63E−02

1.03E−02

8243

SMC1A

2.27E−02

1.07E−02

339327

ZNF546

2.67E−02

1.14E−02

1478

CSTF2

6.14E−03

1.50E−02

79022

TMEM106C

4.48E−04

1.64E−02

84253

GARNL3

2.01E−02

2.14E−02

9361

LONP1

2.18E−02

2.27E−02

23381

SMG5

2.95E−02

2.67E−02

9532

BAG2

1.32E−02

2.74E−02

55131

RBM28

1.23E−02

2.91E−02

4038

LRP4

1.06E−03

4.07E−02

83941

TM2D1

3.81E−02

4.84E−02

90355

c5orf30

8.13E−03

6.17E−02

23657

SLC7A11

2.26E−03

7.32E−02

10489

LRRC41

4.73E−02

8.07E−02

65244

SPATS2

3.16E−02

8.16E−02

3913

LAMB2

8.27E−03

8.52E−02

7444

VRK2

1.95E−02

8.66E−02

8807

IL18RAP

1.34E−03

8.75E−02

79739

TTLL7

3.94E−02

8.88E−02

2764

GMFB

7.68E−03

1.00E−01

51253

MRPL37

1.81E−02

1.02E−01

1965

EIF2S1

5.40E−03

1.22E−01

127544

RNF19B

6.66E−03

1.32E−01

60682

SMAP1

4.86E−03

1.46E−01

3931

LCAT

1.92E−02

1.48E−01

56829

ZC3HAV1

4.36E−02

1.70E−01

5514

PPP1R10

4.66E−02

1.81E−01

8565

YARS

5.54E−04

1.90E−01

55056

FLJ10038

3.73E−02

2.03E−01

10626

TRIM16

2.97E−02

2.04E−01

10487

CAP1

4.08E−02

2.29E−01

10570

DPYSL4

1.36E−02

2.35E−01

201229

LYRM9

5.58E−03

2.66E−01

4359

MPZ

3.41E−02

3.00E−01

79989

TTC26

8.51E−04

3.53E−01

308

ANXA5

1.85E−04

4.24E−01

57181

SLC39A10

2.64E−02

4.35E−01

5256

PHKA2

4.46E−02

4.40E−01

6611

SMS

1.48E−02

4.49E−01

95681

CEP41

1.59E−02

4.70E−01

64175

P3H1

1.38E−03

4.81E−01

6897

TARS

2.13E−02

5.20E−01

10206

TRIM13

1.47E−02

5.23E−01

55212

BBS7

9.59E−03

5.35E−01

3939

LDHA

3.08E−04

5.37E−01

201798

TIGD4

3.85E−02

5.43E−01

169200

TMEM64

8.06E−03

5.66E−01

84725

PLEKHA8

3.97E−02

5.96E−01

5097

PCDH1

1.37E−02

6.23E−01

84085

FBXO30

6.83E−03

6.56E−01

8790

FPGT

2.03E−02

7.22E−01

79879

CCDC134

2.67E−04

8.10E−01

3312

HSPA8

3.49E−03

9.06E−01

11096

ADAMTS5

4.80E−04

9.14E−01

51520

LARS

2.06E−03

9.46E−01

80723

SLC35G2

3.38E−02

9.46E−01

90110

LOC90110

4.47E−02

NA

  1. A summary of the results of the survival analysis of the mRNAs identified by LRSC. A total of 75 genes were prognostic in the TCGA HCC cohort as indicated by a significant log-rank result; 29 of these were also prognostic in the LIRI-JP cohort, indicated here in bold. NA—Not applicable for testing as gene not available in validation dataset